- Citations, last 5 years
- 23
- Works, last 5 years
- 6
- h-index
- 17
- Scientists listed
- 1
- Grants since 2016
- 100
Grants received
2025–2027 · research · R43
Development and Commercialization of Sialoglycan-Recognizing Probes
Jian Zhang · 490 BioTech (United States) · funded by National Institutes of Health
2025–2028 · research · R42
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome
Michaela Christina Kollisch-Singule · 490 BioTech (United States) · funded by National Institutes of Health
2025–2026 · research · R43
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
Jasdave Chahal · 490 BioTech (United States) · funded by National Institutes of Health
2025 · research · R43
Development of a GBP-based glycosylation analysis system
Brian B. Haab · 490 BioTech (United States) · funded by National Institutes of Health
2025–2027 · research · R43
Development of TACA Glycan Library and Related Glycomics Products
Jian Zhang · 490 BioTech (United States) · funded by National Institutes of Health
2024–2026 · research · R41
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury
Livia Agnes Veress · 490 BioTech (United States) · funded by National Institutes of Health
2024–2025 · research · R43
Field-Deployable, low-Cost Point-of-Need urine test strips for mobile quantification of SUD medication drugs and their metabolites
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2024–2026 · research · R41
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury
Livia Agnes Veress · 490 BioTech (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Integration of Compliance Chambers into Diaphragm Displacement Pump to Double the Pumping Flow of Pediatric Paracorporeal Pulsatile Ventricular Assist Device
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2023–2024 · research · R41
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
Rui Chang · 490 BioTech (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2023–2024 · grant · Standard Grant
SBIR Phase I: Point-of-Care Diagnostic Tool for Identifying Extended Spectrum β-Lactamase E. Coli in Urinary Tract Infection
Di Kang · 490 BioTech (United States) · funded by National Science Foundation
2023–2025 · research · R43
Pediatric Transapical Double Lumen Cannula with Integrated Compliance Chambers Doubles Flow of Paracorporeal Pulsatile VAD
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2023–2025 · research · R41
Protection of transplanted heart function by regulation of Na/K pump activity
Wei Chen · 490 BioTech (United States) · funded by National Institutes of Health
2023–2025 · research · R41
Novel Small Molecule Drug Candidate for the Prevention of Bronchopulmonary Dysplasia
Michaela Christina Kollisch-Singule · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Intensified, High-Rate Reductive Immobilization of Hexavalent Chromium
Fatemeh Shirazi · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R41
Increasing efficiency of sdFv production in a tobacco-based system for synthetic platelet design
Seema Nandi · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R43
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies
Khalid Iqbal · 490 BioTech (United States) · funded by National Institutes of Health
2022–2023 · research · R43
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies
Khalid Iqbal · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · cooperative agreement · U44
A treatment drug for triple negative breast cancer
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R43
Low-dose RNA vaccine platform for tickborne flaviviruses
Christian W. Mandl · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · cooperative agreement · U44
A treatment drug for triple negative breast cancer
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2022–2025 · research · R43
Development of a salt-based nanomedicine for non-muscle invasive bladder cancer
Zhi Liu · 490 BioTech (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Intensified, High-Rate Reductive Immobilization of Hexavalent Chromium
Fatemeh Shirazi · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R41
SymHeal: A novel therapy for treating non-healing diabetic ulcers
Seema Nandi · 490 BioTech (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
Jasdave Chahal · 490 BioTech (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
Jasdave Chahal · 490 BioTech (United States) · funded by National Institutes of Health
2022 · research · R43
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
Christian W. Mandl · 490 BioTech (United States) · funded by National Institutes of Health
2022–2024 · research · R42
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome
Michaela Christina Kollisch-Singule · 490 BioTech (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine
Jasdave Chahal · 490 BioTech (United States) · funded by National Institutes of Health
2021–2026 · research · R42
2-HOBA for Treatment of Pulmonary Hypertension
John A Rathmacher · 490 BioTech (United States) · funded by National Institutes of Health
2021–2023 · research · R41
Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis
John A Rathmacher · 490 BioTech (United States) · funded by National Institutes of Health
2021–2022 · research · R43
RNA-based multi-antigen vaccine for SARS-CoV-2
Christian W. Mandl · 490 BioTech (United States) · funded by National Institutes of Health
2021–2022 · research · R41
Protection of donor kidneys with synchronization modulation electric field (SMEF)
Wei Chen · 490 BioTech (United States) · funded by National Institutes of Health
2021–2024 · research · R41
Development of a radiation-activatable nanoparticle for lung cancer therapy
Zhi Liu · 490 BioTech (United States) · funded by National Institutes of Health
2021–2026 · research · R44
Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2021–2022 · research · R43
Crosslinkable Tissue Particles for Regenerating Craniofacial Bone in an Ovine Model
Jakob Townsend · 490 BioTech (United States) · funded by National Institutes of Health
2021–2024 · research · R42
Protection of donor kidneys with synchronization modulation electric field (SMEF)
Wei Chen · 490 BioTech (United States) · funded by National Institutes of Health
2021–2025 · research · R42
Protection of donor kidneys with synchronization modulation electric field (SMEF)
Wei Chen · 490 BioTech (United States) · funded by National Institutes of Health
2021–2023 · cooperative agreement · U34
Repurposing Incyclinide for the Treatment of Hospitalized COVID-19 Patients
Joseph Scaduto · 490 BioTech (United States) · funded by National Institutes of Health